Browse Companies
Discover companies hiring across Latin America
Loading companies...
Discover companies hiring across Latin America
Showing 1 to 5 of 5 companies
Bringing non-invasive brain stimulation from the hospital to the home
Indero, based in Montreal, is a contract research organization (CRO) with a focus on clinical research in dermatology and rheumatology. Founded in 2000 as Innovaderm, the company rebranded in 2025 to reflect its expanded expertise. With over 25 years of experience, Indero operates globally across North America, Europe, Latin America, and Asia-Pacific, providing full-service solutions for biotech and pharmaceutical sponsors. The company offers a range of services, including protocol design, patient recruitment, trial monitoring, and support for studies from proof-of-concept to Phase III. Indero specializes in complex endpoints and interdisciplinary approaches for conditions that overlap between dermatology and rheumatology. It also maintains a dedicated research clinic for in-house studies and invests in research and development to enhance methodologies and publish peer-reviewed work. Indero's therapeutic focus includes treatments for atopic dermatitis, psoriasis, and various inflammatory conditions affecting the musculoskeletal system.
IQVIA Holdings Inc. is a global leader in advanced analytics, technology solutions, and clinical research services for the life sciences industry. Formed in 2016 through the merger of Quintiles Transnational and IMS Health, and rebranded in 2017, the company is headquartered in Durham, North Carolina, and employs around 86,000 to 88,000 people across more than 100 countries. IQVIA leverages its proprietary IQVIA Connected Intelligence(TM), which combines healthcare-grade data, AI-powered analytics, and domain expertise to enhance clinical development and improve healthcare outcomes. The company offers a comprehensive suite of services, including advanced analytics, technology solutions, and clinical research services. Its capabilities encompass healthcare market intelligence, AI-driven insights, decentralized clinical trials, and full-service contract research organization (CRO) functions. IQVIA serves a diverse range of clients, from small biopharma firms to large pharmaceutical companies, focusing on addressing modern challenges in healthcare and accelerating medical advancements for better patient outcomes.
Precision for Medicine is a global clinical research organization (CRO) that specializes in biomarker-driven research and development services for life sciences companies, focusing on oncology, rare diseases, and precision medicine. As part of the Precision Medicine Group, it employs 3,500 experts across 40 locations worldwide. The company integrates clinical operations, laboratory expertise, and advanced data sciences to enhance drug development from early stages through to approval. The company offers a comprehensive range of services, including clinical trial management, biospecimen and sample management, laboratory and analytical services, and consulting. Its capabilities support complex trials with a focus on real-time processing and data integration. Precision for Medicine also provides high-quality human biospecimens and custom-processed samples, along with analytical outputs that aid in the development of in vitro diagnostics. Recognized for its innovative solutions in drug development, the company emphasizes collaborative and agile approaches to optimize clinical trial design and execution.
Precision Medicine Group is a specialty services company founded in 2012, headquartered in Bethesda, Maryland. It supports pharmaceutical and life sciences clients at every stage of product development and commercialization, operating across 35 locations in North America, Europe, and Asia-Pacific. The company consists of two main platforms. Precision for Medicine offers biomarker-driven research and development, providing clinical research organization (CRO) services, laboratory expertise, and AI-enabled data solutions. Precision AQ focuses on commercialization services, assisting life science organizations from product launch through maturity. Precision Medicine Group aims to enhance the drug development process by integrating science, technology, data, and human expertise to drive commercial success.